MetaCap

West Pharmaceutical Services Inc. (WST)

NYSE: WSTHealth CareMedical/Dental InstrumentsUSD

390.30-6.39 (-1.61%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

WST stock chart

Technical analysis

Key statistics

All statistics
Market cap
$27.19B
Dividend yield
0.23% ($0.88)
Ex-dividend date
Jul 29, 2026
52-week range
223.83 – 438.27
Day range
389.75 – 400.90
Volume / Avg
623.34K / 619.05K
Beta
—

52-week range

$223.83$438.27

WST stock today

West Pharmaceutical Services (WST) closed at $390.30 on Nov 20, down 1.61% (-$6.39), versus the S&P 500's 3.70% decline. At this level, WST sits in the middle of its 52-week range of $223.83 to $438.27: 10.9% below the high, set on Oct 29, 2026 and 74.4% above the low. WST is up 41.9% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 44.0%.

At 43.8x trailing earnings, West Pharmaceutical Services trades above the peer-group median of 26.5x. Its forward P/E of 37.6x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. West Pharmaceutical Services pays an annual dividend of $0.88 per share, a 0.23% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About West Pharmaceutical Services

Company profile

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.

Industry
Medical/Dental Instruments
CEO
Mr. Michel Lagarde
Headquarters
Exton, PA
Employees
10,000

Financial highlights

Full financials

In fiscal 2025, West Pharmaceutical Services generated $3.07 billion in revenue, up 6.3% from fiscal 2024. Net income was $493.7 million (+0.2% year over year), for a net margin of 16.1% versus a median of 20.1% in the prior 5 years. Gross margin was 35.9% (up from 34.5%) and operating margin 19.0%.

West Pharmaceutical Services annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$3.07B$2.89B$2.95B$2.89B$2.83B
Growth+6.25%-1.92%+2.18%+1.95%+31.89%
Net income$493.70M$492.70M$593.40M$585.90M$661.80M
EPS (diluted)$6.79$6.69$7.88$7.73$8.67

Analyst forecast

Forecast

Consensus (16 analysts)

strong_buy

Avg. price target

$471.00+20.68%

  • Strong buy 3
  • Buy 12
  • Hold 0
  • Sell 0
  • Strong sell 1

Target range

Low $340.00High $500.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 29, 2026
EPS actual vs est.
$1.96 vs $2.18
Surprise
-10.09%

Dividends

Dividend history
Annual dividend
$0.88
Last payment
$0.22
Ex-dividend date
Jul 29, 2026

WST news

All WST news

West Pharmaceutical Services peers

Health Care sector
WST peer companies
CompanyPrice% ChgMarket capCompare
DXCMDexCom Inc.79.32-1.08%$29.58Bvs WST
RMDResMed Inc.235.63-0.53%$33.14Bvs WST
SOLVSolventum Corporation84.50-1.52%$14.36Bvs WST
GKOSGlaukos Corporation237.31-0.33%$14.05Bvs WST
BAXBaxter International Inc.25.390.00%$13.14Bvs WST
PENPenumbra Inc.319.12-0.28%$12.58Bvs WST
PODDInsulet Corporation133.17-2.96%$9.24Bvs WST
GMEDGlobus Medical Inc. Class A66.89-2.49%$8.86Bvs WST

Indexes, lists and sector

West Pharmaceutical Services stock FAQ

What is West Pharmaceutical Services's stock price today?

WST last traded at $390.30 as of Nov 20, 4:00 PM EST, down 1.61% on the day. Prices are delayed at least 15 minutes.

Does West Pharmaceutical Services pay a dividend?

Yes. West Pharmaceutical Services pays $0.88 per share annually, a 0.23% yield. The most recent dividend of $0.22 had an ex-dividend date of Jul 29, 2026.

What is WST's P/E ratio?

WST trades at a trailing P/E ratio of 43.80 and a forward P/E of 37.55, compared with a median of 26.5 for its closest peers.

Is West Pharmaceutical Services in the S&P 500?

Yes. West Pharmaceutical Services (WST) is a constituent of the S&P 500 index.

Who is West Pharmaceutical Services's CEO?

Mr. Michel Lagarde is the chief executive officer of West Pharmaceutical Services Inc., which has about 10,000 employees.

Has WST ever split its stock?

Yes. The most recent WST stock split was a 2-for-1 split on Sep 27, 2013, one of 4 splits on record.

What is the WST 52-week high?

The 52-week high for WST is $438.27 and the 52-week low is $223.83. The stock is currently 10.9% below its high.

Compare WST